Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EERS Global Technologies is a private Montreal-based medical technology company focused on in-ear audio and hearing-science solutions for high-noise environments, with a current emphasis on MRI and interventional MRI settings. Its flagship offering is an MRI Audio Platform that combines proprietary eartips, in-ear voice capture, hearing protection, and software to improve communication among patients, technologists, physicians, and care teams during scans and procedures. The company positions its technology as helping reduce patient stress and anxiety while improving workflow, safety, and team coordination in noisy clinical environments. Beyond healthcare, EERS has described broader capabilities in hearing protection, biometric and wellness monitoring, and brain-computer-interface-related in-ear technologies, though its visible commercial focus appears centered on medical audio solutions. EERS operates as an applied R&D and product development company with expertise in real-time signal processing, in-ear biomechanics, and manufacturable hardware-software systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EERS Global Technologies.